Patient-reported behavior and problems in using glaucoma medications.
about
Brimonidine in the treatment of glaucoma and ocular hypertensionCombination medical treatment for primary open angle glaucoma and ocular hypertension: a network meta-analysisQuality of Life in Glaucoma: A Review of the LiteratureClinical effectiveness of brinzolamide 1%-brimonidine 0.2% fixed combination for primary open-angle glaucoma and ocular hypertensionCombination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focusFixed-dose combination of tafluprost and timolol in the treatment of open-angle glaucoma and ocular hypertension: comparison with other fixed-combination products.Development of the conceptual framework for the Eye-Drop Satisfaction Questionnaire (EDSQ) in glaucoma using a qualitative studyScoring and psychometric properties of the Eye-Drop Satisfaction Questionnaire (EDSQ), an instrument to assess satisfaction and compliance with glaucoma treatmentPredictors of additional intraocular pressure reduction in patients changed to latanoprost/timolol fixed combinationDevelopment and validation of a predictive model for nonadherence with once-daily glaucoma medicationsAn exploratory study of factors influencing glaucoma treatment adherenceConsiderations in glaucoma therapy: fixed combinations versus their component medications.Adjunctive therapy patterns in glaucoma patients using prostaglandin analogs.Safety and efficacy of fixed-combination travoprost/timolol in patients with open-angle glaucoma or ocular hypertension not controlled with timolol monotherapyMorphometric changes in the rat optic nerve following short-term intermittent elevations in intraocular pressure.A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components.Randomized trial of brinzolamide/brimonidine versus brinzolamide plus brimonidine for open-angle glaucoma or ocular hypertensionEvaluation of the efficacy and safety of a new device for eye drops instillation in patients with glaucoma.Determinants of medication adherence to topical glaucoma therapy.Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic reviewGlaucoma patient expression of medication problems and nonadherence.The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity.Patient satisfaction with glaucoma therapy: reality or myth?Twenty-four hour efficacy with the dorzolamide/timolol-fixed combination compared with the brimonidine/timolol-fixed combination in primary open-angle glaucoma.Pharmacotherapy and Adherence Issues in Treating Elderly Patients with Glaucoma.Individualised patient care as an adjunct to standard care for promoting adherence to ocular hypotensive therapy: an exploratory randomised controlled trialComparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial.Inter-Rater Agreement in the Assessment of Video Recordings of Eye Drop Instillation by Glaucoma Patients.Impact of the introduction of generic latanoprost on glaucoma medication adherence.Efficacy and tolerability of brinzolamide/brimonidine suspension and prostaglandin analogs in patients previously treated with dorzolamide/timolol solution and prostaglandin analogs.Fixed Combination of Travoprost and Timolol Maleate Reduces Intraocular Pressure in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Prospective Multicenter Open-Label Study.Attributes Associated with Adherence to Glaucoma Medical Therapy and its Effects on Glaucoma Outcomes: An Evidence-Based Review and Potential Strategies to Improve Adherence.Cost of glaucoma treatment in a developing country over a 5-year periodFixed combination of travoprost and timolol maleate reduces intraocular pressure in Japanese patients with primary open-angle glaucoma or ocular hypertension: analysis by prostaglandin analogue.Applying the resources and supports in self-management framework to examine ophthalmologist-patient communication and glaucoma medication adherence.Brinzolamide 1%/timolol versus dorzolamide 2%/timolol in the treatment of open-angle glaucoma or ocular hypertension: prospective randomized patient-preference study.Bimatoprost/timolol fixed combination (BTFC) in patients with primary open angle glaucoma or ocular hypertension in Greece.Impact of a health communication intervention to improve glaucoma treatment adherence. Results of the interactive study to increase glaucoma adherence to treatment trial.Patterns of adherence behaviour for patients with glaucoma.Fixed-combination and emerging glaucoma therapies.
P2860
Q22305848-FA305E40-2A57-4365-9F83-5F8793A69A3EQ24192958-AF791B4E-5ACD-4B21-A529-8A7EC9C1973FQ26747891-6199A79E-C796-4FD2-9D20-74153391D94EQ26773219-49FAA089-EE92-46FF-9E39-0A1C66505812Q26830201-215098A7-33F9-4CF4-BA85-CDE7CAD292D2Q30588260-EF46EB49-2718-4B5A-A5D6-64A04F032B22Q33293442-12F793E4-4F08-4BFC-A4E0-50E17CA84689Q33528152-18F7549A-911C-489B-8FD4-82DE42FC9535Q33546682-CF9011CF-64A9-4154-87BC-4C2CB11C184DQ33594601-4B20030C-71FA-4AD4-8B65-D4E21A42E9D7Q33597692-AFC6D296-B368-497A-918B-F675E1F3EE49Q33644139-63F9DCD6-3A04-4DA6-A944-1AA4A752E072Q33769480-71CB64F9-59AD-4BC3-BD6A-D5EB0038E8C7Q34090075-4BA56270-D505-4238-9830-9107BF0D8EE8Q34662227-D4C9FCAF-8FB7-40E3-B005-697FAA05AF30Q34737181-BB48FA12-CF12-4450-9FC0-DABCD17B08D7Q34737217-43DCA09A-6CEC-4129-B280-8A9D7D241621Q35142388-02578F0B-5096-47EB-A4B2-59F8B3694353Q35243409-76CBEEDB-66F5-4EBE-BCA3-4520E098172FQ35327935-FEF68DDB-D71D-4B74-8EFE-07D910C691E6Q35537191-B3CA8DF3-ECF0-4304-A3BC-E67B52CAAEDAQ35571666-587685DA-DB82-43A3-930B-F4E9652EB50CQ35592890-22890500-7AC5-4F5E-8CE3-A26D05B66C6EQ35676220-A65796C9-9C4C-40C2-85AF-4F1E55726075Q35681331-88BF42A8-4D40-4DB0-8BD1-890819AB5DAEQ35820480-4B234251-E01C-4655-8E6E-432B3D202862Q35822206-6D61B3AB-AEF7-4284-B7EC-D1C8692BF648Q35885077-49879F30-0817-4A09-A752-A091D713966EQ35899865-EA83C3E3-F57E-4397-BAD6-3F312C70E9D8Q35995429-8679199E-096E-4ABA-B451-8C57C896BAC6Q36158856-5800D593-41B6-4B2C-9914-550D56431ECCQ36177075-2002DDCD-5E38-47F9-9EE2-980C1AA9342DQ36205359-F22CC96C-CF9D-4960-B023-0D1AA7C497D1Q36239886-D2686179-74CB-4DB1-A000-DDAF2DAB3005Q36344429-CEA8BA9D-E604-4E15-89C1-1168250AEA10Q36352323-58C62457-84B4-4646-9E78-93B17A19D316Q36622405-B2AB4661-4615-4B12-A66F-934A5A1944E0Q36672290-9EAA34D9-9609-42E1-B152-78388A169DF4Q36764753-2282825E-0A28-4DE4-B2F9-03BD2B111A75Q36866626-B047D57D-0D84-4A93-BCB4-915820EFE896
P2860
Patient-reported behavior and problems in using glaucoma medications.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Patient-reported behavior and problems in using glaucoma medications.
@en
Patient-reported behavior and problems in using glaucoma medications.
@nl
type
label
Patient-reported behavior and problems in using glaucoma medications.
@en
Patient-reported behavior and problems in using glaucoma medications.
@nl
prefLabel
Patient-reported behavior and problems in using glaucoma medications.
@en
Patient-reported behavior and problems in using glaucoma medications.
@nl
P2093
P1433
P1476
Patient-reported behavior and problems in using glaucoma medications.
@en
P2093
Betsy Sleath
Bonnie Svarstad
David Covert
Gail Tudor
John E Byrd
P304
P356
10.1016/J.OPHTHA.2005.10.034
P577
2006-02-03T00:00:00Z